title: Screening of pregnant Saudi women for hepatitis B surface antigen.
abstract: BACKGROUND
  The high prevalence of hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg) in pregnant women is considered the most important factor contributing to the higher carrier rate of HBsAg in some populations, including Saudi Arabia. Universal hepatitis B vaccination in infancy was implemented in Saudi Arabia in 1990 to avoid early acquisition of infection. At the same time, another program was launched to vaccinate all school children at school entry as a second target group. The aim of this study was to evaluate the HBsAg prevalence rate in Saudi pregnant women 12 years after launching the program and to assess regional variation, if any.
  
  
  METHODS
  In a cross-sectional study, 2664 pregnant Saudi women were recruited from the five main regions in Saudi Arabia. Blood samples were tested for HBsAg. Positive samples were tested also for HBeAg.
  
  
  RESULTS
  Of 2664 pregnant Saudi women, 65 were positive for HBsAg (2.46%, 95% CI=2.11%-2.69%). Four were positive for HBeAg (0.15%). The HBsAg prevalence rate was higher in Gizan (4.2%) and lower in Tabuk (1.4%) (P=-0.035). Only one case was positive for HBsAg in women under the age of 20 years (1/186), a 0.5% positivity rate in this age group compared with 2.6% in the older age group (P=-0.049 for the one-sided test). A history of surgical procedures was associated with a higher (3%), but not significantly higher rate of HBsAg positivity. No significant association was found between HBsAg positivity and a history of dental procedures or blood transfusion.
  
  
  CONCLUSIONS
  Although the HBsAg prevalence rate among Saudi pregnant women was lower than previously published data, the full impact of the hepatitis B vaccination program in infancy and childhood will take more years to decrease the prevalence rate in pregnant women. The MOH should continue to give the first dose of hepatitis B vaccine at birth to prevent early acquisition, but in the meantime a regional policy can be adopted to deal with the high prevalence rate of HBsAg among pregnant Saudi women.
authors.affiliation: Ministry of Health, Riyadh 11176, Saudi Arabia. yalmazrou@hotmail.com
authors.forename: Yagob Y
authors.initials: YY
authors.lastname: Al-Mazrou
authors.forename: Mohamed
authors.initials: M
authors.lastname: Al-Jeffri
authors.forename: Mohamed K M
authors.initials: MK
authors.lastname: Khalil
authors.forename: Yasser S
authors.initials: YS
authors.lastname: Al-Ghamdi
authors.forename: Ameen
authors.initials: A
authors.lastname: Mishkhas
authors.forename: Mohamed
authors.initials: M
authors.lastname: Bakhsh
authors.forename: Mostafa
authors.initials: M
authors.lastname: Eisa
authors.forename: Mohamed
authors.initials: M
authors.lastname: Nageeb
authors.forename: Salah
authors.initials: S
authors.lastname: Tumsah
mesh_terms: D000328:Adult; D003430:Cross-Sectional Studies; D005260:Female; D006509:Hepatitis B / Q000097:blood / Q000175:diagnosis* / Q000453:epidemiology / Q000517:prevention & control; D006514:Hepatitis B Surface Antigens / Q000097:blood*; D006801:Humans; D017589:Immunization Programs / Q000379:methods; D008403:Mass Screening / Q000379:methods; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000097:blood / Q000175:diagnosis* / Q000453:epidemiology / Q000517:prevention & control; D015995:Prevalence; D012529:Saudi Arabia / Q000453:epidemiology; D014761:Viral Hepatitis Vaccines / Q000627:therapeutic use
chemical_list: D006514:Hepatitis B Surface Antigens; D014761:Viral Hepatitis Vaccines